MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
MicroTech Medical (Hangzhou) Co., Ltd. reported a robust 36.1% increase in operating revenue for the first half of 2024, reaching RMB 150.8 million, with significant contributions from the successful launch of their new CGMS product, AiDEX X. Despite these gains, the company experienced a net loss of RMB 37.7 million, a 102.2% increase from the previous year, mainly due to higher selling expenses associated with the new product launch. However, the company successfully reduced administrative expenses by 12.7% and maintains a strong cash reserve of RMB 1.81 billion.
For further insights into HK:2235 stock, check out TipRanks’ Stock Analysis page.